abstract |
The present invention relates to the novel arylalkane-sulfonamides of formula (I) and their use as active ingredients in the preparation of pharmaceutical compositions. The present invention also relates to processes for the preparation of compounds of formula I, pharmaceutical compositions containing one or more such compounds and their use as endothelin antagonists. |